| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/20/2008 | US7374909 mediated by receptors of the TNF/NGF superfamily of receptors; originally designated CBK, but now designated B1; DNA sequence: vector |
| 05/20/2008 | US7374896 GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity |
| 05/20/2008 | US7374895 Guanosine triphosphate (GTP) binding protein-coupled receptor proteins that bind histamine and are expressed in the brain |
| 05/20/2008 | US7374892 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 05/20/2008 | US7374888 Detecting anti-bacillus antibody in biological samples; biological and chemical warfare agents |
| 05/20/2008 | US7374874 Bacteriophages that infect Bacillus bacteria (Anthrax) |
| 05/20/2008 | US7374763 Foot-and-Mouth Disease virus (FMDV), or their epitopes; vaccine from the grafting of peptide epitopes derived from FMDV into swine antibody CDR loops, FMDV peptide epitopes are cloned by polymerace chain reaction PCR from VP1 gene of FMDV |
| 05/20/2008 | CA2473759C Antibodies for detecting ecstasy-class analytes |
| 05/20/2008 | CA2419698C Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes |
| 05/20/2008 | CA2361681C Method of enhancing salty taste, salty taste enhancer, salty taste seasoning agent and salty taste-enhanced foods |
| 05/15/2008 | WO2008057683A2 Methods for the purification of polypeptide conjugates |
| 05/15/2008 | WO2008056833A1 ANTI-HUMAN Dlk-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO |
| 05/15/2008 | WO2008056759A1 Method for production of dipeptide |
| 05/15/2008 | WO2008056705A1 M cell-specific antibody |
| 05/15/2008 | WO2008055407A1 A surfactant and the chemical synthetic method thereof |
| 05/15/2008 | WO2007084630A3 Mutant jak3 kinase in human leukemia |
| 05/15/2008 | WO2005102378A3 Modular furniture system |
| 05/15/2008 | US20080115244 Therapeutic antibodies comprising protective proteins for use in treatment and prevention of dental caries and streptococal infection; dentristry |
| 05/15/2008 | US20080115243 Transgenic Plants Expressing Intein Modified Proteins and Associated Processes for Bio-Pharmaceutical Production |
| 05/15/2008 | US20080115231 Using peroxisome proliferator activated receptor as tool in detecting compounds which enhance food intake and/or body weight gain; diagnosing and treating eating disorders |
| 05/15/2008 | US20080113933 polynucleotide molecules that encode the Chlamydia polypeptides designated 60 kDa cysteine-rich membrane proteine which can be used to prevent, treat, and diagnose Chlamydia infection |
| 05/15/2008 | US20080113917 A fusion protein expressed in a protease resistant scaffold and protease inhibitor is selected from the group consisting of Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor; capable of modulating human hair growth |
| 05/15/2008 | US20080113906 Sushi Peptide Multimer |
| 05/15/2008 | US20080113896 Nutraceutical, medicament; peptides isoleucine-proline-proline and valine-proline-proline from casein; dietary supplement or a personal care application; topical lotion, gel; emulsion, food, beverage, feed or pet food ingredient |
| 05/15/2008 | US20080113428 Novel Polypeptide Hormone Phosphatonin |
| 05/15/2008 | US20080113412 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses |
| 05/15/2008 | US20080113411 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses |
| 05/15/2008 | US20080113410 Method for Rational Pegylation of Proteins |
| 05/15/2008 | US20080113409 Transient protein expression methods |
| 05/15/2008 | US20080113407 In vivo translation system for incorporation of sulfotyrosine into proteins; directed protein evolution |
| 05/15/2008 | US20080113406 Modified bacteriocins and methods for their use |
| 05/15/2008 | US20080113405 Gene-Cassette For Enhancement Of Protein Production |
| 05/15/2008 | US20080113346 Using allelic variation in uncoupling gene (UCP2/UCP3)sequences as rheumatoid arthritis diagnostic |
| 05/15/2008 | US20080112971 DNA active as a modified vaccinia virus Ankara promoter or active as a promoter in vaccinia virus infected cells; expression cassettes having coding sequence codes for therapeutic proteins or peptides, antigens, antigenic epitopes, antisense RNA or ribozymes; vaccines; genetic vectors; avipoxviruses; |
| 05/15/2008 | US20080112965 Chlamydia OMP antigen |
| 05/15/2008 | US20080112964 Mutant Pneumolysin Proteins |
| 05/15/2008 | US20080112961 Using antibodies to mediate cytotoxicity and treat cell proliferative disorders; immunotherapy |
| 05/15/2008 | US20080112959 Smallpox monoclonal antibody |
| 05/15/2008 | US20080112946 Catalytically active recombinant memapsin and methods of use thereof |
| 05/15/2008 | CA2669731A1 Anti-human dlk-1 antibody showing anti-tumor activity in vivo |
| 05/15/2008 | CA2666308A1 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 05/14/2008 | EP1921137A1 Antibody having inhibitory effect on amyloid fibril formation |
| 05/14/2008 | EP1921090A1 Genetically modified antibody composition |
| 05/14/2008 | EP1920239A2 Detection and measurement of blood-feeding activity |
| 05/14/2008 | EP1920066A1 Cancerous disease modifying antibodies |
| 05/14/2008 | EP1920065A2 Anti-alpha v beta 6 antibodies and uses thereof |
| 05/14/2008 | EP1920061A1 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES |
| 05/14/2008 | EP1919955A1 Cancerous disease modifying antibodies |
| 05/14/2008 | EP1919951A2 Anti-tnf-alpha antibodies and methods of use |
| 05/14/2008 | EP1919942A2 Methods and compositions for enhancing protein folding |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | EP1127160B1 Parallel methods for genomic analysis |
| 05/14/2008 | EP1087997B1 Monoclonal antibodies directed against the g3bp protein, and uses |
| 05/14/2008 | EP1078081B1 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells |
| 05/14/2008 | EP1035132B1 Monoclonal antibody inducing apoptosis |
| 05/14/2008 | EP0833929B1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
| 05/14/2008 | EP0783313B1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 05/14/2008 | EP0772437B9 Compositions for delivery of genetic material |
| 05/14/2008 | EP0763100B1 Method of purification of clostridium difficile toxin a and production of mono-specific antibodies |
| 05/14/2008 | EP0635132B2 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 05/14/2008 | CN101180401A Isolated dipeptides with ACE inhibitor effect |
| 05/14/2008 | CN101180313A Fermentation process for the production of diphtheria toxin |
| 05/14/2008 | CN101180309A Affinity purification of protein |
| 05/14/2008 | CN101177698A Method for preparing fish protein active peptide powder by employing cod skin |
| 05/14/2008 | CN101176502A Method for preparing dope using fresh water fishbone |
| 05/14/2008 | CN101176501A Method for preparing by fresh water non squama fishskin sour method |
| 05/14/2008 | CN101176500A Method for preparing collagen by fresh water non squama fishskin alkali method |
| 05/14/2008 | CN100387713C Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
| 05/14/2008 | CN100387712C Protease variants and compositions |
| 05/14/2008 | CN100387708C Method for high level expression of active lymphotoxin-betareceptor immunoglobulin and purification method therefor |
| 05/14/2008 | CN100387702C Mutant microorganism and method for producing peptide using the same |
| 05/14/2008 | CN100387616C Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/13/2008 | US7371845 MAGE-A3 peptides presented by HLA class II molecules |
| 05/13/2008 | US7371844 Polypeptide of given sequence which binds to receptors; gene expression; use in treatment of osteoporosis, bone loss and raising cyclic AMP levels in cells |
| 05/13/2008 | US7371842 Polynucleotide encoding a 35 KDA protein thats binds to WF00144 |
| 05/13/2008 | US7371838 expression cassette encoding a beta 1,4-N-acetylglucosaminyl (GalNAc) transferase polypeptide; campylobacter jejuni (C. jejuni); host cells; enzyme involved in synthesis of lipooligosaccharides including gangliosides and ganglioside mimics |
| 05/13/2008 | US7371835 p53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 05/13/2008 | US7371832 Polynucleotides encoding molecules associated with cell proliferation |
| 05/13/2008 | US7371828 Extracellular signal-regulated kinase sequences and methods of production and use |
| 05/13/2008 | US7371827 Antibodies against the PRO1126 polypeptide |
| 05/13/2008 | US7371826 Comprising human immunoglobulin g1 fc region, which mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity |
| 05/13/2008 | US7371825 Monoclonal antibody inhibits ability of monocyte chemoattractant protein (MCP) to cause chemotactic migration to monocytic cells and prevents calcium mobilization; diagnosis and treatment of prostate and colon cancer |
| 05/13/2008 | US7371824 PRO6093 polypeptides |
| 05/13/2008 | US7371823 Cyclic nucleotide-gated cation channel subunit 3B (CNG3B) polypeptides |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371818 Comprises chordin-like polypeptide fo diagnosis, pre vention and treatment of bone and cancer disorders; gene therapy; antitumor agents |
| 05/13/2008 | US7371817 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis |
| 05/13/2008 | US7371815 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 05/13/2008 | US7371810 Tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371585 Membranes incorporating recognition moieties |
| 05/13/2008 | US7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability |
| 05/13/2008 | US7371572 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection |
| 05/13/2008 | US7371571 Recombinant mycobacteria overexpressing D-alanine ligase gene and uses therefore |
| 05/13/2008 | US7371558 Genetically modified eschrichia strain which is capable of biocoversion a single cacrbon source into 1, 3 propanediol using fermentation; bioreactors |
| 05/13/2008 | US7371557 Saccharomyces cerevisiae strains for hyper-producing glutathione and γ-glutamylcysteine and processes of use |
| 05/13/2008 | US7371555 Polypeptides having α-H-α-amino acid amide racemase activity and nucleic acids encoding the same |
| 05/13/2008 | US7371550 Protein of given sequence; improved action and substrate specificity; use in diagnosis kits |
| 05/13/2008 | US7371549 Aldolase, and method for producing optically active IHOG and monatin |
| 05/13/2008 | US7371543 Factor VII or VIIa-like molecules |